We are live on
!
Find out more
Vir Biotechnology
143 hedge funds and large institutions have $2.11B invested in Vir Biotechnology in 2020 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 55 increasing their positions, 25 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
120% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 25
114% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 21
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
20% more funds holding
Funds holding: 119 → 143 (+24)
6.82% more ownership
Funds ownership: 55.14% → 61.95% (+6.8%)
12% less capital invested
Capital invested by funds: $2.41B → $2.11B (-$293M)
23% less call options, than puts
Call options by funds: $10.9M | Put options by funds: $14.3M
Holders
143
Holders Change
+24
Holders Change %
+20.17%
% of All Funds
2.53%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.09%
New
45
Increased
55
Reduced
25
Closed
21
Calls
$10.9M
Puts
$14.3M
Net Calls
-$3.34M
Net Calls Change
-$3.42M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$65.2M |
| 2 |
BlackRock
New York
|
+$44.7M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$28.8M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$11.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.9M |
Top Sellers
| 1 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$6.85M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$3.84M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$3.11M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.95M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$2.21M |
